Vizora日本語

SymBio PharmaceuticalsSymBio Pharmaceuticals Limited4582東証グロース医薬品FY ending Dec 2025, consolidated, J-GAAP

SymBio Pharmaceuticals FY ending Dec 2023 results

SymBio Pharmaceuticals brought in ¥5.59B in revenue.

It lost about ¥14 for every ¥100 of sales at the operating level.

Revenue changed -44.1% from the prior year, operating profit -141.3%.

Revenue and profit pattern

Turned to a loss

What changed from last year

FY ending Dec 2022 → FY ending Dec 2023

Revenue
-44.1%¥10B → ¥5.59B
Gross profit
-42.0%¥7.6B → ¥4.41B
Operating income
-141.3%¥1.96B → -¥811.7M
Net income attributable to owners
-266.4%¥1.18B → -¥1.96B
Operating cash flow
-112.1%¥1.61B → -¥194.7M
Free cash flow
-127.3%¥1.57B → -¥427.5M

Where the money goes

FY ending Dec 2022 → FY ending Dec 2023

Where ¥100 of sales goes

For every ¥100 SymBio Pharmaceuticals sells, how much goes where, and how much is kept.

FY ending Dec 2023
Cost of sales
¥21
SG&A
¥93
Operating loss
¥14
Net loss
¥35

Annual margin trends

Gross margin78.9%
FY ending Dec 2019: 30.5%30.5%FY ending Dec 2020: 29.0%29.0%FY ending Dec 2021: 70.3%70.3%FY ending Dec 2022: 75.9%75.9%FY ending Dec 2023: 78.9%78.9%FY19FY20FY21FY22FY23
Operating margin-14.5%
FY ending Dec 2019: -151.6%-151.6%FY ending Dec 2020: -150.9%-150.9%FY ending Dec 2021: 12.3%12.3%FY ending Dec 2022: 19.6%19.6%FY ending Dec 2023: -14.5%-14.5%FY19FY20FY21FY22FY23
Net margin-35.1%
FY ending Dec 2019: -154.2%-154.2%FY ending Dec 2020: -136.9%-136.9%FY ending Dec 2021: 24.6%24.6%FY ending Dec 2022: 11.8%11.8%FY ending Dec 2023: -35.1%-35.1%FY19FY20FY21FY22FY23

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Sources

Show source documents (6)

  • EDINET (FSA Japan)

    有価証券報告書－第21期(2025/01/01－2025/12/31)

    ID S100XNE52026-03-24Open

  • EDINET (FSA Japan)

    有価証券報告書－第20期(2024/01/01－2024/12/31)

    ID S100VGDJ2025-03-25Open

  • EDINET (FSA Japan)

    有価証券報告書－第19期(2023/01/01－2023/12/31)

    ID S100T3FG2024-03-22Open

  • EDINET (FSA Japan)

    訂正有価証券報告書－第18期(2022/01/01－2022/12/31)

    ID S100QG6E2023-03-24Open

  • EDINET (FSA Japan)

    有価証券報告書－第17期(令和3年1月1日－令和3年12月31日)

    ID S100NPZC2022-03-29Open

  • EDINET (FSA Japan)

    有価証券報告書－第16期(令和2年1月1日－令和2年12月31日)

    ID S100L0KX2021-03-24Open

Extracted from XBRL: 41 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image